All News #Library
Rare Diseases
Opus Sets Sights On FDA Talks After Posting Gene Therapy Data
30 Sep 2025 //
GLOBENEWSWIRE
Opus Genetics` OPGx-LCA5 Gets FDA Rare Pediatric Disease Designation
20 Aug 2024 //
GLOBENEWSWIRE
Opus Announces Comp of Dosing of Ph 1/2 of OPGx-LCA5 for Retinal Disease LCA5
26 Mar 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support